Anna Bangiri presented her long-term follow-up findings during the Intracranial Benign oral presentation session of the International Radiosurgery Society Congress (ISRS2026), held in Sydney, Australia at the beginning of June. Her talk focused extensively on evaluating cognitive and Quality of Life (QOL) data for meningioma patients after receiving Stereotactic Radiosurgery (SRS).
By sharing these insights on a global stage, her presentation highlighted the critical role of advanced treatment planning and medical physics in minimizing long-term cognitive side effects, ultimately advocating for better survivorship and long-term care strategies for patients living with benign brain tumors.
